Australian Pharmaceutical Industries Stock Forecast, Price & News

Wall Street analysts have given Australian Pharmaceutical Industries a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Australian Pharmaceutical Industries wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Australian Pharmaceutical Industries is scheduled to release its next quarterly earnings announcement on Friday, October 22nd 2021.
View our earnings forecast for Australian Pharmaceutical Industries.

Australian Pharmaceutical Industries Limited (ASX:API) announced its quarterly earnings data on Wednesday, April, 17th. The company reported $0.05 EPS for the quarter, missing the Zacks' consensus estimate of $0.05 by $0.00.
View Australian Pharmaceutical Industries' earnings history.

Australian Pharmaceutical Industries announced a Interim dividend on Friday, April 23rd. Investors of record on Thursday, June 3rd will be paid a dividend of 0.015 per share on Thursday, June 3rd. This represents a dividend yield of 1.16%. The ex-dividend date of this dividend is Wednesday, May 5th.
View Australian Pharmaceutical Industries' dividend history.

Australian Pharmaceutical Industries pays an annual dividend of A$0.04 per share and currently has a dividend yield of 2.63%.
View Australian Pharmaceutical Industries' dividend history.

Some companies that are related to Australian Pharmaceutical Industries include Air France-KLM (AF), AllDigital (ADGL), ALS (ALQ), Astika (ASKH), Auckland International Airport (AIA), Autogrill (AGL), Automotive Holdings Group (AHG), Autosports Group (ASG), Baltia Air Lines (BLTA), Bapcor (BAP), Brambles (BXB), Brinker International (EAT), Cabcharge Australia (CAB), Cannabis Sativa (CBDS) and Cash Converters International (CCV).
View all of API's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Australian Pharmaceutical Industries investors own include Capricorn Metals (CMM), Austal (ASB), Mod Resources (MOD), Harvey Norman (HVN), Evolution Mining (EVN) and Downer EDI (DOW).

Australian Pharmaceutical Industries trades on the ASX under the ticker symbol "API."

Australian Pharmaceutical Industries has a market capitalization of $0.00 and generates $3.97 billion in revenue each year.

The official website for Australian Pharmaceutical Industries is www.api.net.au.

Australian Pharmaceutical Industries is headquartered at L 5 250 Camberwell Rd, MELBOURNE, VIC 3124, Australia.

Australian Pharmaceutical Industries' mailing address is L 5 250 Camberwell Rd, MELBOURNE, VIC 3124, Australia. The company can be reached via phone at +61-3-88553000.